Type 2 diabetes and glucagon-like peptide-1 receptor agonists Type 2 diabetes is a chronic adverse health condition in which the body either resists the effects of insulin or does not produce enough to keep blood sugar at normal levels
Definitely recommend researching chemyo
The follow-up is straightforward, and in most cases, the explanation is manageable
Additionally, some patients report that their tolerance for very sweet foods decreases while on these medications, with previously enjoyed treats now tasting overly sweet or causing nausea
Focusing on these core nutrition foundations can help support energy, hydration, muscle maintenance, and long-term balance
Your doctor should include recent lab work showing metabolic markers, a detailed weight history spanning at least the past 12 months, documentation of all lifestyle modification efforts with specific dates and outcomes, records of previous weight management medications tried and the reasons they were discontinued, and a Letter of Medical Necessity explaining why a GLP-1 medication is the appropriate next step for your care